CVE-2015-3957: Hospira LifeCare PCA Infusion System before 7.0 stores private keys and certificates, which has unspecified...

Security readout for executives and security teams

Hospira LifeCare PCA infusion systems before version 7.0 stored private keys and certificates. That can undermine trust controls if an attacker can access those secrets. The public CVE record does not specify the practical impact or attack path, so urgency should be based on whether these devices remain in clinical use. Exposure is limited to environments with Hospira LifeCare PCA Infusion System devices running software before 7.0. Healthcare providers and biomedical engineering teams are the likely owners of affected assets. Prioritize discovery and governance if these infusion systems are present. The business risk is patient-care technology exposure with incomplete public impact detail, not a confirmed widespread exploitation event. Mitigation focus: Inventory Hospira LifeCare PCA devices and record software versions.; Prioritize review of any units running software before 7.0.; Check FDA, ICS-CERT, and vendor guidance before changing clinical devices..

Prepared

Jun 13, 2026, 22:22 UTC (UTC+00:00)

Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.